Regenxbio Stock Price on October 1, 2024
| RGNX Stock | USD 9.58 0.01 0.10% |
Below is the normalized historical share price chart for Regenxbio extending back to September 17, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Regenxbio stands at 9.58, as last reported on the 26th of November, with the highest price reaching 10.20 and the lowest price hitting 9.57 during the day.
If you're considering investing in Regenxbio Stock, it is important to understand the factors that can impact its price. Regenxbio maintains Sharpe Ratio (i.e., Efficiency) of -0.0457, which implies the firm had a -0.0457% return per unit of risk over the last 3 months. Regenxbio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Regenxbio's Variance of 21.57, risk adjusted performance of (0.03), and Coefficient Of Variation of (1,844) to confirm the risk estimate we provide.
At this time, Regenxbio's Total Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation To Revenue is likely to rise to 0.54 in 2024, whereas Common Stock Total Equity is likely to drop 3,420 in 2024. . At this time, Regenxbio's Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.42 in 2024, whereas Price To Sales Ratio is likely to drop 8.26 in 2024. Regenxbio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of September 2015 | 200 Day MA 14.2159 | 50 Day MA 10.2418 | Beta 1.232 |
Regenxbio |
Sharpe Ratio = -0.0457
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RGNX |
Estimated Market Risk
| 4.73 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Regenxbio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regenxbio by adding Regenxbio to a well-diversified portfolio.
Price Book 1.5747 | Enterprise Value Ebitda (3.37) | Price Sales 5.6286 | Shares Float 40.9 M | Wall Street Target Price 34.8462 |
Regenxbio Main Headline on 1st of October 2024
Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executi... by finance.yahoo.com
Tagworks Pharmaceuticals BV , a precision oncology company using its proprietary Click-to-Release treatment platform to develop a new standard of care for patients suffering from solid tumors by targeting clinically validated tumor markers that so far have remained out of reach of current therapies, today announced the appointment of Ken Mills as Chief Executive Officer and member of the Board of Directors. As part of this planned CEO leadership transition, Marc Robillard, Ph.D., the
Regenxbio Valuation on October 1, 2024
It is possible to determine the worth of Regenxbio on a given historical date. On October 1, 2024 Regenxbio was worth 10.35 at the beginning of the trading date compared to the closed value of 10.21. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Regenxbio stock. Still, in general, we apply an absolute valuation method to find Regenxbio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Regenxbio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Regenxbio's related companies.
| Open | High | Low | Close | Volume | |
| 10.81 | 10.95 | 10.14 | 10.49 | 682,307 | |
10/01/2024 | 10.35 | 10.50 | 9.93 | 10.21 | 1,024,365 |
| 10.19 | 10.34 | 9.90 | 9.92 | 749,428 |
| Backtest Regenxbio | | | Regenxbio History | | | Regenxbio Valuation | Previous | Next |
Regenxbio Trading Date Momentum on October 1, 2024
| On October 02 2024 Regenxbio was traded for 9.92 at the closing time. The top price for the day was 10.34 and the lowest listed price was 9.90 . The trading volume for the day was 749.4 K. The trading history from October 2, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.84% . The trading delta at closing time against the current closing price is 9.21% . |
Regenxbio Fundamentals Correlations and Trends
By evaluating Regenxbio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Regenxbio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Regenxbio Stock history
Regenxbio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Regenxbio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Regenxbio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Regenxbio stock prices may prove useful in developing a viable investing in Regenxbio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 43.7 M | 33.3 M | |
| Net Loss | -252.3 M | -239.7 M |
Regenxbio Quarterly Net Working Capital |
|
Regenxbio Stock Technical Analysis
Regenxbio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Regenxbio Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Regenxbio cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Regenxbio November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Regenxbio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regenxbio shares will generate the highest return on investment. By undertsting and applying Regenxbio stock market strength indicators, traders can identify Regenxbio entry and exit signals to maximize returns
Regenxbio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Regenxbio's price direction in advance. Along with the technical and fundamental analysis of Regenxbio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Regenxbio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (0.98) | |||
| Treynor Ratio | (0.12) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Regenxbio Stock Analysis
When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.